<SEC-DOCUMENT>0001894562-23-000002-index.html : 20230404
<SEC-HEADER>0001894562-23-000002.hdr.sgml : 20230404
<ACCEPTANCE-DATETIME>20230404202229
ACCESSION NUMBER:		0001894562-23-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230404
DATE AS OF CHANGE:		20230404

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LEE ANN L.
		CENTRAL INDEX KEY:			0001723629

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41536
		FILM NUMBER:		23800788

	MAIL ADDRESS:	
		STREET 1:		400 DEXTER AVENUE NORTH
		STREET 2:		SUITE 1200
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98109

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prime Medicine, Inc.
		CENTRAL INDEX KEY:			0001894562
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		21 ERIE ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-465-0013

	MAIL ADDRESS:	
		STREET 1:		21 ERIE ST.
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_168065413914963.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wf-form4_168065413914963.html

Document 1 - RAW XML: wf-form4_168065413914963.xml

</DOCUMENT>
</SEC-DOCUMENT>